Laser-assisted capsulotomy results better than CCC

Article

Femtosecond laser-assisted capsulotomy resulted in better circularity and more predictable size compared with standard manual continuous curvilinear capsulorhexis (CCC) in a prospective, randomized clinical study by researchers in Italy.

Femtosecond laser-assisted capsulotomy resulted in better circularity and more predictable size compared with standard manual continuous curvilinear capsulorhexis (CCC) in a prospective, randomized clinical study by researchers in Italy. They also found that IOL centration was better immediately following surgery and over time for patients who underwent femtosecond laser-assisted capsulotomy. The results are published in the Journal of Cataract & Refractive Surgery.

Candidates for cataract extraction were randomly assigned into 1 of 3 groups, each with 30 eyes of 30 patients:

  • Laser group 1 underwent femtosecond laser–assisted cataract surgery capsulotomy performed with a proprietary laser (LenSx, Alcon),

  • Laser group 2 had femtosecond laser–assisted cataract surgery capsulotomy performed with a proprietary laser (Lensar Laser System, Lensar Inc.), and

  • The manual group underwent manual CCC.

After 7 days, the capsulotomies in both laser groups showed significantly better circularity than did those the CCCs of the manual group. The two laser groups also showed a significant correlation between the intended versus achieved capsulotomy size as well as better IOL centration than the manual group at all timepoints.

Distance visual acuity, both corrected and uncorrected, was not different in a statistically significant way between groups. Residual spherical equivalent and mean absolute error, however, were statistically significantly smaller in the laser groups than in the manual group, and they increased significantly over time in all the groups.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.